» Articles » PMID: 34514500

The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity

Overview
Journal J Infect Dis
Date 2021 Sep 13
PMID 34514500
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circulation of seasonal non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) respiratory viruses with syndromic overlap during the coronavirus disease 2019 (COVID-19) pandemic may alter the quality of COVID-19 surveillance, with possible consequences for real-time analysis and delay in implementation of control measures.

Methods: Using a multipathogen susceptible-exposed-infectious-recovered (SEIR) transmission model formalizing cocirculation of SARS-CoV-2 and another respiratory virus, we assessed how an outbreak of secondary virus may affect 2 COVID-19 surveillance indicators: testing demand and positivity. Using simulation, we assessed to what extent the use of multiplex polymerase chain reaction tests on a subsample of symptomatic individuals can help correct the observed SARS-CoV-2 percentage positivity and improve surveillance quality.

Results: We find that a non-SARS-CoV-2 epidemic strongly increases SARS-CoV-2 daily testing demand and artificially reduces the observed SARS-CoV-2 percentage positivity for the duration of the outbreak. We estimate that performing 1 multiplex test for every 1000 COVID-19 tests on symptomatic individuals could be sufficient to maintain surveillance of other respiratory viruses in the population and correct the observed SARS-CoV-2 percentage positivity.

Conclusions: This study showed that cocirculating respiratory viruses can distort SARS-CoV-2 surveillance. Correction of the positivity rate can be achieved by using multiplex polymerase chain reaction tests, and a low number of samples is sufficient to avoid bias in SARS-CoV-2 surveillance.

Citing Articles

Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness-Valencia Region, Spain, 2010-2021.

Shirreff G, Chaves S, Coudeville L, Mengual-Chulia B, Mira-Iglesias A, Puig-Barbera J Influenza Other Respir Viruses. 2024; 18(10):e70017.

PMID: 39439102 PMC: 11496384. DOI: 10.1111/irv.70017.


Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report.

Nunes M, Thommes E, Frohlich H, Flahault A, Arino J, Baguelin M Infect Dis Model. 2024; 9(2):501-518.

PMID: 38445252 PMC: 10912817. DOI: 10.1016/j.idm.2024.02.008.


The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps.

Wong A, Barrero Guevara L, Goult E, Briga M, Kramer S, Kovacevic A PLoS Pathog. 2023; 19(3):e1011167.

PMID: 36888684 PMC: 9994710. DOI: 10.1371/journal.ppat.1011167.

References
1.
Alwan N . Surveillance is underestimating the burden of the COVID-19 pandemic. Lancet. 2020; 396(10252):e24. PMC: 7836224. DOI: 10.1016/S0140-6736(20)31823-7. View

2.
Eggo R, Scott J, Galvani A, Meyers L . Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model. Proc Natl Acad Sci U S A. 2016; 113(8):2194-9. PMC: 4776522. DOI: 10.1073/pnas.1518677113. View

3.
Hoze N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Severi G . Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study. Lancet Public Health. 2021; 6(6):e408-e415. PMC: 8032222. DOI: 10.1016/S2468-2667(21)00064-5. View

4.
Pullano G, Di Domenico L, Sabbatini C, Valdano E, Turbelin C, Debin M . Underdetection of cases of COVID-19 in France threatens epidemic control. Nature. 2020; 590(7844):134-139. DOI: 10.1038/s41586-020-03095-6. View

5.
Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, Hyypia T . Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis. 2008; 197(3):382-9. DOI: 10.1086/525542. View